Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

34.97
-1.8900-5.13%
Post-market: 35.080.1100+0.31%19:37 EST
Volume:11.44M
Turnover:411.53M
Market Cap:7.96B
PE:65.14
High:37.61
Open:36.71
Low:34.90
Close:36.86
52wk High:72.98
52wk Low:23.97
Shares:227.65M
Float Shares:197.51M
Volume Ratio:0.97
T/O Rate:5.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5369
EPS(LYR):0.5837
ROE:26.21%
ROA:5.56%
PB:13.70
PE(LYR):59.91

Loading ...

Hims & Hers Health Shares Slip 2.8% Premarket After US FDA Chief Says Super Bowl Ad Violated Drug Promotion Rules

THOMSON REUTERS
·
Sep 15

FDA Administrator Says Hims & Hers Health Inc. Super Bowl Ad Violates Drug Promotion Regulations

Stock News
·
Sep 15

Time to Bet on Hims & Hers Health (HIMS)? Analysts Point to Several Growth Catalysts

TIPRANKS
·
Sep 14

US FDA chief says Hims & Hers Super Bowl ad violated drug promotion rules

Reuters
·
Sep 13

Hims & Hers Health Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Sep 12

Hims & Hers Health (HIMS) Gets a Buy from Canaccord Genuity

TIPRANKS
·
Sep 12

BTIG Keeps Their Buy Rating on Hims & Hers Health (HIMS)

TIPRANKS
·
Sep 12

Hims & Hers Still Tied to Weightloss Despite Testosterone Expansion -- Market Talk

Dow Jones
·
Sep 11

Marius Pharmaceuticals, Hims & Hers Collaborate To Expand Access To Oral Testosterone Therapy

Reuters
·
Sep 11

Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to Kyzatrex® (Testosterone Undecanoate) Ciii Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers Platform

THOMSON REUTERS
·
Sep 10

Marius Pharmaceuticals: Kyzatrex Will Be Available to Patients Through Hims & Hers Platform in Coming Months

THOMSON REUTERS
·
Sep 10

U.S. Stock Movers | Hims & Hers Health Inc. (HIMS.US) Surges Over 7% on Exclusive Oral Testosterone Therapy Launch

Stock News
·
Sep 10

Hims & Hers Health Shares up 5% After Co to Launch New Offerings for Men With Low Testosterone

THOMSON REUTERS
·
Sep 10

BRIEF-Hims Debuts Oral Testosterone, Expands Personalized Men’s Health Treatments

Reuters
·
Sep 10

Hims & Hers Health Inc - to Launch Oral Testosterone With Marius Pharmaceuticals in 2026

THOMSON REUTERS
·
Sep 10

Hims & Hers Health Inc - Launches New Men's Health Category for Low Testosterone

THOMSON REUTERS
·
Sep 10

Hims & Hers Health Inc - to Introduce Injectable Testosterone in 2026

THOMSON REUTERS
·
Sep 10

Hims Launches New Category in Men’s Health With Exclusive Branded Oral Testosterone and Expanded Personalized Treatments

THOMSON REUTERS
·
Sep 10

Pre-Bell|U.S. Futures Mixed; Oracle Surges 32%; GameStop Jumps 9%; NIO Sinks 8%; Synopsys Plunges 23%

Tiger Newspress
·
Sep 10

BUZZ-Hims & Hers climbs on report of plans to launch low testosterone treatments

Reuters
·
Sep 10